Brentuximab Vedotin
Advanced Classical Hodgkin Lymphoma: BrECADD Shows Noninferiority to eBEACOPP
SG Tylor
Source – BrECADD According to information from the Phase III HD21 trial (NCT02661503), which included patients with advanced classical Hodgkin ...
98% ORR in Early-Stage Classical Hodgkin Lymphoma with Brentuximab Vedotin + Nivolumab/Chemo
SG Tylor
Source – Seagen Frontline treatment with the combination of brentuximab vedotin (Adcetris), nivolumab (Opdivo), doxorubicin, and dacarbazine led to an ...
